News and media
Coverage of Aquila Bioscience and its Pathogen Capture Technology, plus videos from the Aquila YouTube channel. Most press items are archive coverage; dates are shown where the source gives one.
Press
University of Galway
Protecting lives while harnessing the power of nature (opens in a new tab)
Silicon Republic
Aquila Bioscience collaborates with European Space Agency (opens in a new tab)
Silicon Republic
Muscle atrophy in microgravity environment and multi-omic data analysis (opens in a new tab)
Newstalk · Futureproof
Research on pathogen decontamination in microgravity (opens in a new tab)
Company update · 20–23 March 2025
Aquila Bioscience and Innov8 Labs shortlisted as finalists for the Cosmopack Awards, Cosmoprof Worldwide Bologna
Galway Advertiser
Local medtech company develops mask spray which blocks 99 per cent of pathogens (opens in a new tab)
Silicon Republic
Galway medtech develops mask spray to block 99% of pathogens (opens in a new tab)
HEA · 27 May 2020
Higher Education research activity in response to SARS-CoV-2 (opens in a new tab)
The Irish Times
Innovation is key in battle against Covid-19 (opens in a new tab)
NUI Galway · January 2020
Irish innovation in wipes and masks could help battle emerging coronavirus crisis (opens in a new tab)
GRIPT
An emerging Irish technology may be key to containing the Wuhan coronavirus (opens in a new tab)
Videos
- Aquila's technology removes 99.99% of SARS-CoV-2 (opens in a new tab)
- How ABD technology works (opens in a new tab)
- ABD device animation: emergency PPE (opens in a new tab)
- ABDs being used by Defence Forces Ireland (opens in a new tab)
- ABD use on skin and around the face (opens in a new tab)
- ABD use on surfaces (opens in a new tab)
- ABD technology in supermarkets (opens in a new tab)
- Interview with Lokesh Joshi, founder of Aquila Bioscience (opens in a new tab)
- Aquila Bioscience's research discussed at Arizona State University (opens in a new tab)
- Infection prevention unveiled: delving into cellular and molecular frontiers (opens in a new tab)
